| Name | loricrin cornified envelope precursor protein |
| Description | This gene encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Loricrin is a major structural protein that is predominantly expressed during the late stages of keratinocyte differentiation in the epidermis. It constitutes a key component of the cornified envelope and is essential for assembling the robust, water‐impermeable barrier that protects the skin from external insults, dehydration, and pathogen invasion. In several inflammatory skin disorders—including atopic dermatitis and psoriasis—a marked reduction in loricrin expression contributes to barrier defects, facilitating increased penetration of allergens and microbes and thereby exacerbating inflammation. In these conditions, proinflammatory cytokines such as IL‑4, IL‑13, and TNF‑α are known to downregulate loricrin expression, further impairing the terminal differentiation process of keratinocytes and reducing the overall integrity of the epidermal barrier. Restoration of loricrin levels, as observed following therapeutic interventions that counteract these cytokines, reaffirms its crucial role in maintaining epidermal homeostasis. Collectively, these findings establish loricrin as a pivotal effector in the formation and maintenance of the skin barrier and underscore that its dysregulation is a critical factor in the pathogenesis of chronic skin inflammation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Byung Eui Kim, Donald Y M Leung, Mark Boguniewicz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clim.2007.11.006"}], "href": "https://doi.org/10.1016/j.clim.2007.11.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18166499"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18166499"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Byung Eui Kim, Michael D Howell, Emma Guttman-Yassky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jid.2011.24"}], "href": "https://doi.org/10.1038/jid.2011.24"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21346775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21346775"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Masutaka Furue "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21155382"}], "href": "https://doi.org/10.3390/ijms21155382"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32751111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32751111"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kursad Turksen, Tammy-Claire Troy "}, {"type": "b", "children": [{"type": "t", "text": "Permeability barrier dysfunction in transgenic mice overexpressing claudin 6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Development (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/dev.129.7.1775"}], "href": "https://doi.org/10.1242/dev.129.7.1775"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11923212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11923212"}]}]}]}
|
| NCBI Gene ID | 4014 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LORICRIN has 1,319 functional associations with biological entities spanning 5 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 15 datasets.
Click the + buttons to view associations for LORICRIN from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of LORICRIN gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with LORICRIN gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of LORICRIN gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving LORICRIN gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing LORICRIN protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of LORICRIN gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by LORICRIN gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of LORICRIN gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving LORICRIN protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of LORICRIN gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving LORICRIN protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving LORICRIN protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of LORICRIN gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of LORICRIN gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of LORICRIN gene from the RummaGEO Gene Perturbation Signatures dataset. | |